A citation-based method for searching scientific literature

Thomas Powles, Joseph Paul Eder, Gregg D Fine, Fadi S Braiteh, Yohann Loriot, Cristina Cruz, Joaquim Bellmunt, Howard A Burris, Daniel P Petrylak, Siew-leng Teng, Xiaodong Shen, Zachary Boyd, Priti S Hegde, Daniel S Chen, Nicholas J Vogelzang. Nature 2014
Times Cited: 1709



Antoni Ribas, Jedd D Wolchok. Science 2018
Times Cited: 2675




List of shared articles



Times cited

Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.
Holly K Koblish, Liangxing Wu, Liang-Chuan S Wang, Phillip C C Liu, Richard Wynn, Jonathan Rios-Doria, Susan Spitz, Hao Liu, Alla Volgina, Nina Zolotarjova,[...]. Cancer Discov 2022
3

CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.
Minglu Xiao, Luoyingzi Xie, Guoshuai Cao, Shun Lei, Pengcheng Wang, Zhengping Wei, Yuan Luo, Jingyi Fang, Xingxing Yang, Qizhao Huang,[...]. J Immunother Cancer 2022
0

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition.
Luise Victoria ClaaƟ, Christoph SchultheiƟ, Rebekka Scholz, Lisa Paschold, Donjete Simnica, Volker Heinemann, Sebastian Stintzing, Mascha Binder. Front Oncol 2022
0

Self-Assembly Catalase Nanocomplex Conveyed by Bacterial Vesicles for Oxygenated Photodynamic Therapy and Tumor Immunotherapy.
Jiayu Zhang, Zinan Li, Ling Liu, Longyun Li, Lu Zhang, Yongkun Wang, Jia Zhao. Int J Nanomedicine 2022
2

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Zewei Tu, Qin Ouyang, Xiaoyan Long, Lei Wu, Jingying Li, Xingen Zhu, Kai Huang. Front Immunol 2022
5